Cannabinoid-focused biotechnology company Demetrix announced Thursday it secured $50 million in a Series A funding round led by Tuatara Capital. Another investor is Horizons Ventures, which previously ...
Whether or not you partake in the $30 billion legal cannabis market, the legalization of cannabis in parts of the U.S. and Canada has helped to destigmatize and legalize the use of the cannabinoid ...
Demetrix has raised $50 million in a first round of venture funding to establish high-volume fermentation production of tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. Backers ...
EMERYVILLE, Calif., March 4, 2019 /PRNewswire/ -- Demetrix, Inc., a company with world-class expertise in producing nature's ingredients using fermentation, today announced entry into an exclusive ...
Demetrix – one of a new wave of biotech firms producing cannabinoids via biosynthesis (rather than extracting them from cannabis plants) – has commenced 15,000-liter demo-scale fermentation production ...
Partnership introduces bioactives to global beauty and personal care markets BERKELEY, Calif., April 5, 2022 /PRNewswire/ -- Demetrix and German global specialty chemicals company Evonik, announce a ...
The legalization of cannabis has created many opportunities for researchers to study the compounds in the cannabinoid family and discover new uses for them. Demetrix, a synthetic biology company ...
EMERYVILLE, Calif., March 4, 2019 /PRNewswire/ -- Demetrix, Inc., a company with world-class expertise in producing nature's ingredients using fermentation, today announced entry into an exclusive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results